NRG THERAPEUTICS LTD
11294505Research and experimental development on biotechnology
NRG THERAPEUTICS LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage Herts SG1 2FX United Kingdom
Full company profile for NRG THERAPEUTICS LTD (11294505), an active life sciences and medical technology company based in Stevenage, United Kingdom. Incorporated 5 Apr 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2019–2025)
Cash in Bank
£3.56M
Net Assets
£2.28M
Total Liabilities
£2.19M
Turnover
N/A
Employees
7
Debt Ratio
49%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 30 Apr Year End | 2024 30 Apr Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (4)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 7 | Nov 2022 | Series A |
| Investor 8 | Nov 2022 | Series A |
| Investor 9 | Nov 2022 | Series A |
See all 4 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Emma Johnson | Director | British | United Kingdom | 2 Jul 2025 | Active |
| Laurence Daniel Paul Barker | Director | British | United Kingdom | 2 Jul 2025 | Active |
| Nessi, Claudio | Director | Swiss | Switzerland | 30 Jun 2022 | Active |
See all 16 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Parkinson's Research Ventures Limited
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Grant Hawthorne
Ceased 30 Jun 2022
Neil Derek Miller
Ceased 30 Jun 2022
Parkinson's Research Ventures Limited
Ceased 1 Jul 2022
Anthony Richard Rutter
Ceased 30 Jun 2022
Parkinson's Uk
Ceased 27 Jun 2019
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 19 Apr 2026 | Confirmation Statement | Confirmation statement made on 4 Apr 2026 with updates | |
| 24 Feb 2026 | Capital | Allotment of shares (GBP 8,162.7627) on 24 Feb 2026 | |
| 4 Feb 2026 | Officers | Termination of Laurence Daniel Paul Barker as director on 2 Feb 2026 | |
| 4 Feb 2026 | Officers | Appointment of Georgia Rose Frost as director on 2 Feb 2026 | |
| 12 Dec 2025 | Officers | Termination of Emma Johnson as director on 10 Dec 2025 |
Confirmation statement made on 4 Apr 2026 with updates
Allotment of shares (GBP 8,162.7627) on 24 Feb 2026
Termination of Laurence Daniel Paul Barker as director on 2 Feb 2026
Appointment of Georgia Rose Frost as director on 2 Feb 2026
Termination of Emma Johnson as director on 10 Dec 2025
Recent Activity
Latest Activity
Confirmation statement made on 4 Apr 2026 with updates
1 months ago on 19 Apr 2026
Allotment of shares (GBP 8,162.7627) on 24 Feb 2026
3 months ago on 24 Feb 2026
Termination of Laurence Daniel Paul Barker as director on 2 Feb 2026
4 months ago on 4 Feb 2026
Appointment of Georgia Rose Frost as director on 2 Feb 2026
4 months ago on 4 Feb 2026
Termination of Emma Johnson as director on 10 Dec 2025
6 months ago on 12 Dec 2025